True or False: Diabetes Stats 2017
October 31, 2017
Can you sort out diabetes facts from fiction? The latest diabetes statistics from the CDC may surprise you.
Julie Bowen
T2D Study Guide, October: SGLT2 Inhibitors, GLP-1 Agonists, CV Outcomes
October 24, 2017
At-a-glance: SGLT2 inhibitors, GLP-1 agonists, insulin vs insulin, and more—a look at what’s new, what’s next.
Interesting Endo: AFib, Bone Health, and Obesity
September 12, 2017
At-a-Glance: Studies you may find of interest look at AFib in T1DM, new fracture risk data, obesity outcomes, and more.
Endocrinology News Quiz: Obesity and Osteoporosis
August 24, 2017
What's new in research on bisphosphonates, body-fat measurement, prebiotics, and insulin dosing? Find out with our quiz.
Interesting T2D: Gaming, Drinking, and Diabetes Outcomes
August 22, 2017
Slide Show: Highlights of new research on online diabetes games, benefits of alcohol, and predictors of T2DM remission.
Interesting Endo: Fracture Risk, Obesity, and Sleep
August 14, 2017
A roundup of the latest research on osteoporotic fracture risk, bariatric surgery outcomes, and effects of sleep on BMI.
Interesting T2DM: ED, Early Menopause and Diabetes Risk
July 25, 2017
A top-line look at the latest news: novel risk factors, insulin vs insulin; and predictors of weight loss success.
Interesting Endo: Obesity and Osteoporosis
July 14, 2017
Browse new research on: diabetes agents preferred in osteoporosis patients, an alternative to BMI, and interventions that work for pediatric obesity.
Interesting T2DM: FDA News & Diabetes Risk
May 12, 2017
Our May list includes an app for titration of basal insulin, GI effects of GLP-1 agonists, and lifestyle intervention studies.
Interesting T2DM: Pharmacotherapy & Obesity Outcomes
April 12, 2017
Our April list includes CV events with DPP-4 or SGLT2 inhibitors vs. insulin, and impact of obesity on nonalcoholic fatty liver disease and thyroid function.
